Advertisement

Use of Medical Services by Methylphenidate-Treated Children in the General Population

  • Anton R. Miller
    Correspondence
    Address correspondence to Dr Anton R. Miller, Room L408, Centre for Community Child Health Research, Children's and Women's Health Centre of British Columbia, 4480 Oak St, Vancouver, British Columbia, Canada BC V6H 3V4
    Affiliations
    From the Centre for Community Child Health Research (Drs Miller, Raina, and Armstrong) Children's and Women's Health Center of British Columbia, Vancouver, British Columbia, Canada

    Department of Pediatrics (Drs Miller and Armstrong), University of British Columbia, Vancouver, British Columbia, Canada
    Search for articles by this author
  • Jamie C. Brehaut
    Affiliations
    Ottawa Health Research Institute (Dr Brehaut), Ottawa Hospital, Ottawa, Ontario, Canada
    Search for articles by this author
  • Parminder Raina
    Affiliations
    From the Centre for Community Child Health Research (Drs Miller, Raina, and Armstrong) Children's and Women's Health Center of British Columbia, Vancouver, British Columbia, Canada

    Department of Health Care and Epidemiology (Dr Raina), University of British Columbia, Vancouver, British Columbia, Canada

    Department of Clinical Epidemiology and Biostatistics (Dr Raina), McMaster University, Hamilton, Ontario, Canada
    Search for articles by this author
  • Kimberlyn M. McGrail
    Affiliations
    Centre for Health Services and Policy Research (Dr McGrail), University of British Columbia, Vancouver, British Columbia, Canada
    Search for articles by this author
  • Robert W. Armstrong
    Affiliations
    From the Centre for Community Child Health Research (Drs Miller, Raina, and Armstrong) Children's and Women's Health Center of British Columbia, Vancouver, British Columbia, Canada

    Department of Pediatrics (Drs Miller and Armstrong), University of British Columbia, Vancouver, British Columbia, Canada
    Search for articles by this author
      Objectives.—To examine selected medical services for children treated for attention-deficit/hyperactivity disorder (ADHD) in a general population setting with universal health insurance.
      Design.—Retrospective analysis of administrative prescription and health services databases spanning from 1990 to 1996.
      Setting.—British Columbia, Canada.
      Patients.—Children (<19 years of age) who had received the psychostimulant methylphenidate (MPH; Ritalin) on a chronic basis (chronic-MPH group), who had received MPH on any other basis (nonchronic-MPH group), and who were in a no-MPH comparison group.
      Main Outcome Measures.—The number of individuals who received any of the following services based on claims submitted by qualified practitioners: 1) emergency care, 2) critical care, 3) injury-related diagnostic and treatment services, 4) complementary and alternative medical (CAM) care, and 5) other diagnostic and treatment services (audiometry and allergy testing).
      Results.—Prevalence of services users was higher among MPH-treated than nontreated children for all types of services (except critical care services in the chronic-MPH group) after adjusting for effects of age, sex, socioeconomic status, and geographic setting, with odds ratios ranging from 1.49 to 3.17. There were no differences between the 2 MPH-treated groups.
      Conclusions.—Children treated with MPH for ADHD or presumed ADHD are more frequent users of a wide range of medical services than are other children. Findings support and extend existing evidence of increased use of medical services by this population of children. Findings have implications for service planning, including injury prevention, with these children. High utilization of audiometric, allergy, and CAM services warrants further scrutiny.

      KEY WORDS

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Academic Pediatrics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Scahill L
        • Schwab-Stone M
        Epidemiology of ADHD in school-age children.
        Child Adolesc Psychiatr Clin N Am. 2000; 9: 541-555
        • Barkley RA
        Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 2nd ed. Guildford Press, New York, NY1998
        • Wender EH
        Attention-deficit/hyperactivity disorder: is it common? Is it overtreated?.
        Arch Pediatr Adolesc Med. 2002; 156: 209-210
        • Evenson B
        The trouble with Ritalin.
        National Post. April 2, 2001; (News): A8
        • Safer DJ
        • Zito JM
        Pharmacoepidemiology of methylphenidate and other stimulants for the treatment of attention deficit hyperactivity disorder.
        in: Greenhill LL Osman BB Ritalin Theory and Practice. Mary Anne Liebert, New York, NY2000: 7-26
        • Brehaut JC
        • Miller A
        • Raina P
        • McGrail KM
        Childhood behavior disorders and injuries among children and youth: a population-based study.
        Pediatrics. 2003; 111: 262-269
        • Guevara J
        • Lozano P
        • Wickizer T
        • et al.
        Utilization and cost of health care services for children with attention-deficit/hyperactivity disorder.
        Pediatrics. 2001; 108: 71-78
        • Leibson CL
        • Katusic SK
        • Barbaresi WJ
        • et al.
        Use and costs of medical care for children and adolescents with and without attention-deficit/hyperactivity disorder.
        JAMA. 2001; 285: 60-66
        • Chan E
        • Zhan C
        • Homer CJ
        Health care use and costs for children with attention-deficit/hyperactivity disorder: national estimates from the medical expenditure panel survey.
        Arch Pediatr Adolesc Med. 2002; 156: 504-511
        • Chamberlayne R
        • Green B
        • Barer ML
        • et al.
        Creating a population-based linked health database: a new resource for health services research.
        Can J Public Health. 1998; 89: 270-273
        • Dosa NP
        • Boeing NM
        • Ms N
        • Kanter RK
        Excess risk of severe acute illness in children with chronic health conditions.
        Pediatrics. 2001; 107: 499-504
        • DiScala C
        • Lescohier I
        • Barthel M
        • Li G
        Injuries to children with attention deficit hyperactivity disorder.
        Pediatrics. 1998; 102: 1415-1421
        • Eisenberg DM
        • Davis RB
        • Ettner SL
        • et al.
        Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey.
        JAMA. 1998; 280: 1569-1575
        • Simpson N
        • Roman K
        Complementary medicine use in children: extent and reasons. A population-based study.
        Br J Gen Pract. 2001; 51: 914-916
        • Adesman AR
        • Altshuler LA
        • Lipkin PH
        • Walco GA
        Otitis media in children with learning disabilities and in children with attention deficit disorder with hyperactivity.
        Pediatrics. 1990; 85: 442-446
        • Grundfast KM
        • Berkowitz RG
        • Conners CK
        • Belman P
        Complete evaluation of the child identified as a poor listener.
        Int J Pediatr Otorhinolaryngol. 1991; 21: 65-78
        • Boris M
        • Mandel FS
        Foods and additives are common causes of the attention deficit hyperactive disorder in children.
        Ann Allergy. 1994; 72: 462-468
        • Tryphonas H
        • Trites R
        Food allergy in children with hyperactivity, learning disabilities and/or minimal brain dysfunction.
        Ann Allergy. 1979; 42: 22-27
        • British Columbia Provincial Health Officer.
        A report on the health of British Columbians: Provincial Health Officer's annual report 1999. Ministry of Health and Ministry Responsible for Seniors, Victoria, BC2000
        • Ng E
        • Wilkins R
        • Perras A
        How far is it to the nearest hospital? Calculating distances using the Statistics Canada Postal Code Conversion File.
        Health Rep. 1993; 5: 179-188
        • Health Canada.
        Survey of attention deficit hyperactivity disorder diagnosis and treatment among Canadian physicians. Final report. Health Canada, Therapeutic Products Program, Ottawa, ON1999
        • Ruel JM
        • Hickey CP
        Are too many children being treated with methylphenidate?.
        Can J Psychiatry. 1992; 37: 570-572
        • Boles M
        • Lynch FL
        • DeBar LL
        Variations in pharmacotherapy for attention deficit hyperactivity disorder in managed care.
        J Child Adolesc Psychopharmacol. 2001; 11: 43-52
        • Rowland AS
        • Umbach DM
        • Stallone L
        • et al.
        Prevalence of medication treatment for attention deficit-hyperactivity disorder among elementary school children in Johnston County, North Carolina.
        Am J Public Health. 2002; 92: 231-234
        • Barbaresi WJ
        • Katusic SK
        • Colligan RC
        • et al.
        How common is attention-deficit/hyperactivity disorder? Incidence in a population-based birth cohort in Rochester, Minn.
        Arch Pediatr Adolesc Med. 2002; 156: 217-224
        • American Academy of Child and Adolescent Psychiatry.
        Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyperactivity disorder.
        J Am Acad Child Adolesc Psychiatry. 1997; 36: 85S-121S
        • Chermak GD
        • Somers EK
        • Seikel JA
        Behavioral signs of central auditory processing disorder and attention deficit hyperactivity disorder.
        J Am Acad Audiol. 1998; 9: 78-84
        • McGee R
        • Stanton WR
        • Sears MR
        Allergic disorders and attention deficit disorder in children.
        J Abnorm Child Psychol. 1993; 21: 79-88
        • Gaitens T
        • Kaplan BJ
        • Freigang B
        Absence of an association between IgE-mediated atopic responsiveness and ADHD symptomatology.
        J Child Psychol Psychiatry. 1998; 39: 427-431
        • Carter CM
        • Urbanowicz M
        • Hemsley R
        • et al.
        Effects of a few food diet in attention deficit disorder.
        Arch Dis Child. 1993; 69: 564-568
        • Vickers A
        • Zollman C
        ABC of complementary medicine. The manipulative therapies: osteopathy and chiropractic.
        BMJ. 1999; 319: 1176-1179
        • Brue AW
        • Oakland TD
        Alternative treatments for attention-deficit/hyperactivity disorder: does evidence support their use?.
        Altern Ther Health Med. 2002; 8 (64-72): 68-70
        • Eisenberg DM
        • Kessler RC
        • Foster C
        • et al.
        Unconventional medicine in the United States. Prevalence, costs, and patterns of use.
        N Engl J Med. 1993; 328: 246-252
        • Kozyrskyj AL
        • Mustard CA
        Validation of an electronic, population-based prescription database.
        Ann Pharmacother. 1998; 32: 1152-1157
        • Tamblyn R
        • Lavoie G
        • Petrella L
        • Monette J
        The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec.
        J Clin Epidemiol. 1995; 48: 999-1009
        • Iezzoni LI
        Assessing quality using administrative data.
        Ann Intern Med. 1997; 127: 666-674
        • Roos LL
        • Roos NP
        • Cageorge SM
        • Nicol JP
        How good are the data? Reliability of one health care data bank.
        Med Care. 1982; 20: 266-276
        • Roos LL
        • Nicol JP
        • Johnson CF
        • Roos NP
        Using administrative databanks for research and evaluation.
        Evaluation Quarterly. 1979; 3: 236-255